Amarin Corp Plc (AMRN)

[Tatsumaki]

If it's not on the drug label, it's not being promoted. Statins were successful because high cholesterol was advertised as a problem leading to CVD issues and the label lowered cholesterol. Lovaza was successful because high Trigs was advertised as a problem leading to CVD issues and it lowered Trigs.

hsCRP, Lp(a), LDL size, oxidation markers, etc... etc... etc... until commercials show up on TV and website popups telling people those markers are important and if out of a good range they are at risk of a heart attack or any other disease, and Vascepa can them in line, none of them matter to the market.

The problem has to be sold first. Then the drug marketed to fix it.